We previously found that PD-1/PD-L1 expression in primary stage II/III CRC tumors is associated with poor prognosis and correlates with the expression of TGF-β and forkhead box P3 (FOXP3) [10]. This evidence concerns the gene TGFB1 and colorectal carcinoma.